ClinicalTrials.gg

Program

TRD205

A development code. Also written as “TRD205 tablets”, “TRD205 Tablets, oral; 400 mg initial dose, then 200 mg q12h for 3 doses; total 4 doses” and “TRD205 Tablets, oral; 800 mg initial dose, then 400 mg q12h; total 4 doses”.

In Sino Biopharmaceutical's pipeline, AT2R拮抗剂. Its studies are mostly in Neuralgia · Hallux Valgus, led by Sino Biopharmaceutical.

Furthest: phase 2, since Jul 31, 20255 company-led studies, 4 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sino Biopharmaceutical54 open or runningphase 2since Jul 31, 2025Jan 19, 2024none ahead
  • Named in Sino Biopharmaceutical’s own pipeline as TRD205, phase 2, as of Nov 16, 2026 (source).

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jan 19, 2024First study: phase 1 study in HealthyFirst studyNCT07123428 · 151 enrolled · China
  2. Jul 29, 2025Phase 1 study in Postoperative Analgesia After Unilateral Hallux Valgus Correction SurgeryNCT07121023 · 32 planned · China
  3. Jul 31, 20252 phase 2 studiesNCT07123402, NCT07121101
  4. Apr 8, 2026Phase 2 study in Postoperative Analgesia After Unilateral Hip ArthroplastyNCT07543796 · 200 planned · China

TargetBeta

“AT2R拮抗剂”the company's pipeline, read by Claude · source

Other programs on AGTR2

ProgramCompanyFurthest phaseStudies
LY4065967Eli Lillyphase 27

Studies

All 5 led by companies developing it, newest first. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07543796Postoperative Analgesia After Unilateral Hip Arthroplasty · China2RecruitingJun 27, 2026200
NCT07123402Chronic Postoperative Neuralgia · China2By invitationApr 20, 2026184
NCT07121101Postoperative Analgesia After Unilateral Hip Arthroplasty · China2Not yet recruitingNov 20, 202540
NCT07121023Postoperative Analgesia After Unilateral Hallux Valgus Correction Surgery · China1Not yet recruitingDec 27, 202532
NCT07123428Healthy · China1CompletedNov 27, 2024151

How it is read

Names in the registry

  • “TRD205 tablets”, 9 entries
  • “TRD205 Tablets, oral; 400 mg initial dose, then 200 mg q12h for 3 doses; total 4 doses”, 1 entry
  • “TRD205 Tablets, oral; 800 mg initial dose, then 400 mg q12h; total 4 doses”, 1 entry
  • “TRD205 Tablets, oral; 1200 mg initial dose, then 600 mg q12h; total 4 doses”, 1 entry
  • “TRD205”, 1 entry

Codes read as this program: TRD205.

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.